Visit COVID-19 resources

[Skip to Content]

Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study – (Eye Journal AOP)

Oct 30
2015

Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study Eye advance online publication, October 30 2015. doi:10.1038/eye.2015.199 Authors: C Bruè, A Pazzaglia, C Mariotti, M Reibaldi & A Giovannini

  • 30 October 2015

Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis – (Eye Journal AOP)

Oct 30
2015

Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis Eye advance online publication, October 30 2015. doi:10.1038/eye.2015.208 Authors: H Q Lu, E Q Wang, T Zhang & Y X Chen

  • 30 October 2015

Comment on ‘The Royal College of Ophthalmologists Guidelines on retinal vein occlusions’ – (Eye Journal AOP)

Oct 30
2015

Comment on ‘The Royal College of Ophthalmologists Guidelines on retinal vein occlusions’ Eye advance online publication, October 30 2015. doi:10.1038/eye.2015.210 Author: D S J Ting

  • 30 October 2015

Ultrastructure of medial rectus muscles in patients with intermittent exotropia – (Eye Journal AOP)

Oct 30
2015

Ultrastructure of medial rectus muscles in patients with intermittent exotropia Eye advance online publication, October 30 2015. doi:10.1038/eye.2015.213 Authors: J Yao, X Wang, H Ren, G Liu & P Lu

  • 30 October 2015

Impact of telephone consent and potential for eye donation in the UK: the Newcastle Eye Centre study – (Eye Journal AOP)

Oct 30
2015

Impact of telephone consent and potential for eye donation in the UK: the Newcastle Eye Centre study Eye advance online publication, October 30 2015. doi:10.1038/eye.2015.216 Authors: D S J Ting, J Potts, M Jones, T Lawther, W J Armitage & F C Figueiredo

  • 30 October 2015